Fed. Circ. Urged Not To Reverse Jazz's Orange Book Delisting
By Kelly Lienhard · January 17, 2023, 9:40 PM EST
Avadel CNS Pharmaceuticals LLC has asked the Federal Circuit to immediately remove patent protection for Jazz Pharmaceuticals' narcolepsy drug even though Jazz is appealing a district court order to delist a patent for the treatment, arguing...
To view the full article, register now.